Welcome to LookChem.com Sign In|Join Free

CAS

  • or

156817-72-0

3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE is a heterocyclic organic compound with a molecular formula C7H8BrN2. It features a bromine atom and a five-membered ring with nitrogen, resulting in a pyridine structure. 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE is known for its unique structure and reactivity, making it a valuable intermediate in the synthesis of various biologically active molecules and pharmaceutical drugs.

156817-72-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 156817-72-0 Structure

  • Basic information

    1. Product Name: 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE
    2. Synonyms: 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE
    3. CAS NO:156817-72-0
    4. Molecular Formula: C7H9BrN2
    5. Molecular Weight: 201.06376
    6. EINECS: N/A
    7. Product Categories: Fused Ring Systems;Halides
    8. Mol File: 156817-72-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 346.3±15.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.73±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C(protect from light)
    8. Solubility: N/A
    9. PKA: 5.91±0.20(Predicted)
    10. CAS DataBase Reference: 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE(156817-72-0)
    12. EPA Substance Registry System: 3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE(156817-72-0)

  • Safety Data

    1. Hazard Codes: T
    2. Statements: 25
    3. Safety Statements: 45
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 156817-72-0(Hazardous Substances Data)

156817-72-0 Usage

Uses

Used in Pharmaceutical Industry:
3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE is used as a building block for the synthesis of various biologically active molecules and pharmaceutical drugs. Its unique structure and reactivity contribute to the development of potential treatments for neurological disorders, cancer, and other diseases.
Used in Academic Research:
3-BROMO-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE is utilized in academic research for the exploration of novel chemical reactions and the discovery of new drug candidates. Its properties and reactivity make it a promising compound for advancing scientific knowledge and identifying innovative therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 156817-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,8,1 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 156817-72:
(8*1)+(7*5)+(6*6)+(5*8)+(4*1)+(3*7)+(2*7)+(1*2)=160
160 % 10 = 0
So 156817-72-0 is a valid CAS Registry Number.

156817-72-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine

1.2 Other means of identification

Product number -
Other names 3-bromoimidazo[1,2-a]piperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:156817-72-0 SDS

156817-72-0Relevant articles and documents

ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

-

Paragraph 0939, (2017/03/14)

Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.

NOVEL SUBSTITUTED IMIDAZOLE DERIVATIVES

-

Page/Page column 57, (2010/11/27)

The present invention relates to a compound represented by Formula [I] or a pharmaceutically acceptable salt or ester thereof: wherein: X1, X2, X3, and X4, which may be identical or different, are each C or N, provided that none to two of X1, X2, X3, and X4 is/are N; Y is CH or N; R1, R1', R2, R2', R3, R3', R4, and R4', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R5 is a hydrogen atom or a methyl group; R6 and R7, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R8 and R8', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R9 is an aryl group or a heteroaryl group which may be substituted; and n is an integer from 1 to 3, and a PLK1 inhibitor or an anticancer agent containing the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 156817-72-0